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ABSTRACT
Tip110 expression regulates hematopoiesis, but the regulatory mechanisms 
during hematopoiesis are not fully understood. There are a number of putative 
microRNA (miRNA) binding sites identified within the Tip110 3′ untranslated region 
(3′UTR). In this study, we determined the relationship among Tip110 miRNA, Tip110 
expression and self-renewal and differentiation of human CD34+ hematopoietic cells. 
Using a Tip110 3UTR-based reporter gene assay, 11 miRNA showed the specific activity 
toward the Tip110 3′UTR and down-regulated constitutive Tip110 mRNA expression. 
When human cord blood CD34+ cells were differentiated, Tip110 mRNA expression 
showed significant decreases. Concurrently, five miRNA showed significant increases, 
five miRNA showed significant decreases, and one miRNA remained unchanged. 
To further assess the roles of miRNA in Tip110 expression and self-renewal and 
differentiation of human CD34+ hematopoietic cells, human cord blood CD34+ cells 
were transduced to express the full-length Tip110 3′UTR RNA. Expression of the 
Tip110 3′UTR RNA led to significant increases of Tip110 mRNA, and the number of 
hematopoietic stem cells and progenitor cells. Taken together, these results show 
important roles of Tip110 miRNA in Tip110 expression control and Tip110 regulation 
of hematopoiesis and offer a possibility of using Tip110 miRNA or 3′UTR as a strategy 
to maintain human CD34+ hematopoietic cells.
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INTRODUCTION
Hematopoietic stem cells (HSCs) have the potential 
to self-renew for maintaining life-long hematopoiesis as 
well as for the production of multiple types of mature 
hematopoietic cells. It is important to understand 
how hematopoiesis is regulated in order to develop 
strategies for the enhanced production and use of HSCs. 
Understanding post-transcriptional regulation from genetic 
programs coming from intrinsic and extrinsic mechanisms 
will accelerate such progress.
MicroRNAs (miRNAs) are short non-coding RNAs 
and about 22 nucleotides in length, they regulate gene 
expression at a post-transcriptional level by inducing 
mRNA degradation and translational inhibition. Several 
miRNAs play a role in the regulation of hematopoietic 
cell differentiation [1]. How miRNAs regulate HSC self-
renewal and progenitor cell lineage commitment is not 
well characterized. Examples of this regulation include 
miR-125a/b effects on HSC survival, in part through 
proapoptotic targets, Bmf and KLF13 [2–4]. miR-126 
regulates HSC functions via the PI3K/AKT/GSK3β axis 
[5]. miR-29a has been implicated in early hematopoietic 
regulation [6]. Recently, we have reported that miR-
124 specifically binds to Tip110 and regulates Tip110 
expression followed by differentiation of human cord 
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blood (CB) CD34+ cells, and production of hematopoietic 
progenitor cells (HPCs) in vitro [7]. 
Analyzing miRNA binding sites within the 
3′UTR is important for understanding gene regulation. 
Many different RNA-binding proteins and miRNAs 
are predicted to interact with the 3′ untranslated region 
(3′UTR) Tip110 based on Tip110 sequences and structure 
[7]. Tip110 is an essential gene expressed in the earliest 
cells of adult bone marrow hematopoietic development. 
Tip110 protein is highly expressed in embryonic stem 
cells (ESCs) and HSCs, but is rapidly down-regulated 
following differentiation of these cells. Tip110 is 
important in regulation of HSC hematopoiesis through 
regulation c-myc [8, 9]. In addition, Tip110 is important 
in regulation of ESC through maintaining expression of 
pluripotent factors including NANOG, OCT-4, and SOX2 
[10]. In this study, we were interested in understanding the 
relationship between Tip110 miRNA, Tip110 expression 
and self-renewal and differentiation of human CD34+ 
hematopoietic cells. We identified a group of miRNA that 
targeted Tip110 3′UTR and regulated Tip110 expression. 
We further demonstrated that ectopic expression of 
the Tip110 3′UTR RNA in human core blood CD34+ 
cells (enriched for HSCs and HPCs) led to increased 
constitutive Tip110 expression and the number of HSCs 
and HPCs during differentiation.
RESULTS
Tip110 3′UTR is targeted by more than 10 
different miRNAs 
We have previously shown that miR-124 down-
regulates Tip110 expression by directly targeting its 3′ 
UTR [7]. We have also shown that Tip110 expression is 
important for hematopoiesis [8]. To determine whether 
there would be other potential miRNA binding sites 
within the Tip110 3′UTR, we used two popular programs 
(TargetScanHuman 6.2 and microRNA.org) and analyzed 
the miRNA binding sites within the Tip110 3′UTR. We 
found a total of 14 miRNA binding sites with the Tip110 
3′UTR (Figure 1A). The detailed seed sequence sites 
of the 14 miRNAs (11 different sequences including 
3 repeats) were provided in Table 1. To determine the 
specificity of the miRNAs toward the Tip110 3′UTR, we 
transfected 293T with a Tip110 3′UTR Luc-reporter gene 
and the mimic of each miRNA (Table 2). Compared to the 
control, all these 11 miRNAs led to significant decreases 
of the Tip110 3′UTR-dependent luciferase reporter gene 
activities, with the most decreases for miR-300 and the 
least decreases with miR-193 (Figure 1B). Except for 
miR-214, all other miRNA led to decreases in Tip110 
mRNA expression to various degrees (Figure 1C) and in 
parallel decreases in Tip110 protein expression (data not 
shown). 
Human core blood CD34+ cell differentiation, 
Tip110 expression, and miRNA expression 
We have previously shown that miR-124 is 
expressed in human core blood hematopoietic progenitor 
cells (HPCs) and it specifically binds to the Tip110 3′UTR 
and has a regulatory effect on core blood HPCs [7]. Next, 
we decided to evaluate expression of those identified 
miRNA during core blood CD34+ cell differentiation. We 
first determined the number of CD34+ cells and rigorously 
defined hematopoietic stem cells (HSC, CD34+CD38−
CD45RA−CD90+CD49f+ cells) on day 1 and day 7 
(CD34+ cells isolated from core blood counted as day 0). 
The purified cells were assessed for Tip110 expression by 
qRT-PCR. Core blood CD34+ cells cultured on days 1 and 
7 were used to reflect undifferentiated and differentiating 
cells, respectively. The percentage of CD34+ cells was 
over 95% on day 1 and 30% on day 7 (Figure 2A). 
CD34+CD38−CD45RA−CD90+CD49f+ cells decreased 
by two thirds on day 7 compared to day 1 (Figure 2B). 
Tip110 was highly expressed on day 1 and decreased by 
90% on day 7 (Figure 2C), which was consistent with 
our previous report that expression of Tip110 decreases 
as the cells differentiate [3]. We then determined the 
expression levels of 11 different miRNAs using this 
model. miR-214 showed the lowest expression level with 
no changes between day 1 and 7 (Figure 3A). We defined 
this expression as 1 (relative expression level calculation 
based on (CT) from qRT-PCR results). Expression levels of 
the other miRNAs were calculated as fold changes based 
on the miR-214 expression level of 1. miR-148, miR-
494, miR-124, miR-193, and miR-300 showed increased 
expression levels from day 1 to 7. miR-148 showed 
very high expression levels (2272 to 6517 fold changes 
compared with that of miR-214) (Figure 3B), while miR-
132, miR-186, miR-199, miR-338, and miR-219 showed 
decreased expression from day 1 to 7 (Figure 3C). 
Expression level changes suggest that these miRNAs may 
be involved in core blood CD34+ cell function and their 
differentiation.
Tip110 3′UTR RNA expression led to increased 
Tip110 protein and mRNA expression levels
Since the Tip110 3′UTR is a target of the above 
mentioned miRNAs, we took advantage of the effective 
competing endogenous RNA (ceRNA) strategy over 
the individual miRNAs [11–13]. Namely, we expressed 
Tip110 3′UTR RNA (Figure 4A) and used it as a decoy to 
compete with constitutive Tip110 3′UTR for any potential 
(identified and unidentified) Tip110 miRNAs. 293T were 
transfected with a plasmid expressing the full-length 
Tip110 3′UTR RNA or an empty vector control. Western 
blotting showed that Tip110 protein was expressed at 
least 3 times greater than the control (Figure 4B). We also 
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Table 1: Potential miRNA binding sequences(seed) for Tip110 3′UTR 
Position 24–30 of Tip110 3′UTR
Hsa-miR-124-3p.2
5′ ...CUGGGAGACAGGAAAUGCCUUAC... 
                                            |  |  |  |  |  |  | 
3'       CGUAAGUGGCGCACGGAAUU 
Position 69–75 of Tip110 3′UTR
Hsa-miR-148b-3p
5′ ...CCCACCACCCAGCAGUGCACUGG... 
                                           |  |  |  |  |  |  |
3′     UGUUUCAAGACACUACGUGACU
Position 82–88 of Tip110 3′UTR
Hsa-miR-214-5p
5′ ...AGUGCACUGGGGAUGGACAGGCC... 
                                       |  |  |  |  |  |  |
3'    CGUGUCGUUCACAUCUGUCCGU
Position 1022–1028 of Tip110 3′UTR
Hsa-miR-193a/b-3p
5′ ...AACAGCAACAGCAUUGGCCAGUU... 
                                            |  |  |  |  |  |  |
3'     UGACCCUGAAACAUCCGGUCAA
Position 633–639 of Tip110 3′UTR
Hsa-miR-132-3p
5′ ...GUGCCACCUGCUGUGGACUGUUU... 
                           |  |  |  |  |      |  |  |  |  |  |  | 
3'     GCUGGUACCGACAUCUGACAAU
Position 310–319 of Tip110 3′UTR
Hsa-miR-494
5′ ...ACAGUUGUCC--AAAUGUUUCU...
    |  |  |     :  |  |          |  |  |  |  |  |  |
3′  CUCCAAAGGGCACAUACAAAGU
Position 550–572 of Tip110 3′UTR
Hsa-miR-494
5′ ...GUCAGCCAUUGUUUCAUGUUUCC...
    :  :  |  |     |     |  |  |  |  |  |  |
3′  CUCCAAAGGGCACA-UACAAAGU
Position 380–30 of Tip110 3′UTR
Hsa-miR-186
5′ ...CACAUGUGCCCGUCAUUCUUUU...
          |   |  |  |  |  |  |
3′  UCGGGUUUUCCUCUUAAGAAAC
Position 931–951 of Tip110 3′UTR
Hsa-miR-199a-5p
5′ ...UUAUA-GCAGUUUG-ACACUGGA...
    |  :  |    |     |  |  |  :  |  |    |  |  |  |  |  |  |
3′  CUUGUCCAUCAGACUUGUGACCC
Position 437–443 of Tip110 3′UTR
Hsa-miR-219a-1-3p
5′ ...CUCAGUUCUAGCUGUUCAACUCU...
                        |  |  |  |  |  |  | 
3'     GCCCUGCAGGUCUGAGUUGAGA
Position 443–449 of Tip110 3′UTR
Hsa-miR-300
5′ ...UCUAGCUGUUCAACUCUUGUAUG...
                      |  |  |  |  |  |  | 
3'     UCUCUCUCAGACGGGAACAUAU
Table 2: miRNA mimics sequences (seed sequences) used for targeting Tip110 3′UTR 
miRNA mimic name Sequence
hsa-miR-124-3p UAAGGCACGCGGUGAAUGCC
hsa-miR-148b-3p UCAGUGCAUCACAGAACUUUGU
hsa-miR-214-5p UGCCUGUCUACACUUGCUGUGC
hsa-miR-494 UGAAACAUACACGGGAAACCUC
hsa-miR-186-5p CAAAGAAUUCUCCUUUUGGGCU
hsa-miR-132-3p UAACAGUCUACAGCCAUGGUCG
hsa-miR-338-3p UCCAGCAUCAGUGAUUUUGUUG
hsa-miR-494 UGAAACAUACACGGGAAACCUC
hsa-miR-214-5p UGCCUGUCUACACUUGCUGUGC
hsa-miR-199a-3p ACAGUAGUCUGCACAUUGGUUA
hsa-miR-193a-3p AACUGGCCUACAAAGUCCCAGU
hsa-miR-300 UAUACAAGGGCAGACUCUCUCU
hsa-miR-219-1-3p AGAGUUGAGUCUGGACGUCCCG
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determined the constitutive Tip110 mRNA expression 
using primers specifically targeted at different regions of 
the Tip110 mRNA transcripts (Table 3). Primer pair Q1 
spanned the open reading frame of Tip110 and was used 
to determine the constitutive Tip110 mRNA expression. 
Primer pair Q2 spanned the first poly(A) site of the 3′UTR 
(PA1), and primer pair Q3 spanned the second poly(A) 
site of the 3′UTR (PA2). Both Q2 and Q3 were used to 
determine both the constitutive and transfected Tip110 
3′UTR RNA expression.  Consistent with constitutive 
Tip110 protein expression (Figure 4B), constitutive Tip110 
mRNA from 3′UTR transfection was about 3 times greater 
than the control (Figure 4C). Compared to the control, the 
3′UTR mRNA expression from the 3′UTR transfection 
was about 25–34 fold more than the constitutive Tip110 
3′UTR mRNA using primer pairs Q2 and Q3 (Figure 4D 
and 4E). These findings confirm the feasibility of using the 
Tip110 3′UTR (other than individual Tip110 miRNA) to 
up-regulate Tip110 expression.
Tip110 3′UTR RNA expression led to increased 
HSC and colony-forming units derived from 
human CB CD34+ cells
To determine the potential roles of Tip110 miRNA 
in self-renewal and differentiation of human CD34+ 
hematopoietic cells, we next expressed the Tip110 
3′UTR RNA in CB CD34+ cells. We transduced human 
CB CD34+ cells with lentiviruses expressing the Tip110 
3′UTR RNA on day 1, and determined Tip110 expression 
as well as the number of rigorously defined HSCs on day 
5. Similarly to the results with 293T, the Tip110 3′UTR 
Figure 1: miRNAs specifically target the Tip110 3′UTR. (A) Schematic of the Tip110 3′UTR region with predicted miRNA 
binding sites (Tip110 miRNA). (B and C) 293T were transfected with pLightSwitch-Tip110.3′UTR and miR-124, miR-148, miR-214, miR-
494, miR-186, miR-338, miR-132, miR-199, miR-193, miR-330, or miR-219. Forty-eight hours after transfection, cells were harvested 
for cell lysates followed by the luciferase reporter assay (B) or for RNA isolation followed by qRT-PCR for Tip110 RNA expression (C). 
The fold changes of Tip110 mRNA expression were calculated using β-actin as the reference. pTK-βgal plasmid was included to normalize 
the transfection efficiency variations among all transfections. The data are the mean ± SEM of triplicates and are representative of three 
independent experiments.
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RNA from the transduction was about 10 times higher 
compared to the control, assessed using both primer pairs 
Q2 and Q3 (Figure 5A). Meanwhile, constitutive Tip110 
mRNA expression was increased about 2 fold resulting 
from the Tip110 3′UTR RNA expression, assessed 
using primer pair Q1 (Figure 5A). Tip110 3′UTR RNA 
expression in CB CD34+ cells also increased the number 
of rigorously defined human HSCs (Figure 5B). To assess 
whether the Tip110 3′UTR RNA expression would affect 
functionally assayable hematopoietic progenitor cells, 
a portion of these transduced CD34+ cells were subject 
to the colony assay. The cells transduced to express the 
Figure 2: Human core blood CD34+ cell differentiation and Tip110 expression. Human core blood CD34+ cells were isolated, 
cultured for 1 day (D1) or 7 days (D7), and stained followed by flow cytometry analysis for the CD34+ percentage (A) or CD34+CD38-
CD45RA-CD90+CD49f+ cells (Y axis represents the number of cells out of 1 million cells) (B), or harvested for RNA isolation followed 
by qRT-PCR for Tip110 mRNA expression (C), which was calculated using β-actin as a reference. The data are the mean ± SEM of 
triplicates and are representative of three independent experiments. 
Figure 3: Effects of human core blood CD34+ cell differentiation on Tip110 miRNA expression. Human core blood CD34+ 
cells were isolated, cultured for 1 day (D1) or 7 days (D7), and harvested for RNA isolation followed by qRT-PCR for miR-214 (A), miR-
148, miR-494, miR-124, miR-193, and miR-300 (B), and miR-132, miR-186, miR-199, miR-338, and miR-219 (C). The data are mean ± 
SEM and are representative of three independent experiments.
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Tip110 3′UTR RNA gave rise to about 2-fold increases 
in number of granulocyte macrophage (CFU-GM), 
multipotential (CFU-GEMM), and the total progenitors, 
compare to the control (Figure 5C). These results support 
the notion that Tip110 miRNA likely contributes to Tip110 
expression, which in turn regulates self-renewal and 
differentiation of human CD34+ hematopoietic cells. 
DISCUSSION
We identified more than 10 different miRNA 
binding sites on the Tip110 3′UTR. The specificity of 
these miRNAs for the 3′UTR of Tip110 was tested using 
a Tip110 3′UTR luciferase reporter gene assay. Those 
miRNAs were shown to be specific targets for the Tip110 
3′UTR. Five miRNAs showed high levels of expression 
in core blood CD34+ cells and were down-regulated 
with differentiation; while 5 miRNAs showed low levels 
of expression in core blood CD34+ cells and were up-
regulated with differentiation. To protect the integrity 
of the Tip110 3′UTR from degradation by miRNAs and 
to maintain Tip110 protein expression during the core 
blood CD34+ cell culture, we transduced human core 
blood CD34+ cells to express the Tip110 3′UTR RNA 
to compete the constitutive Tip110 3′UTR for Tip110 
miRNAs. Ectopic expression of the Tip110 3′UTR RNA 
led to increased expression of constitutive Tip110 mRNA 
and protein expression (Figure 6). The relevance of our 
study is supported by our previous publications showing 
that up-regulation of Tip110 plays important roles in 
hematopoiesis [7, 8, 10].
 From the analysis of the expression levels of 
these 11 miRNAs in core blood CD34+ cells cultured 
on day 1 vs. their differentiation on day 7, we grouped 
the miRNA expression pattern into three categories. The 
first showed no expression changes from day 1 to day 7, 
and included only miR-214. Its expression level was the 
lowest confirmed to this point. The second group that had 
a low expression level on day 1 and a high expression 
level on day 7 included miR-148, miR-494, miR-124, 
miR-193, and miR-300. This group of miRNAs might be 
important for regulating genes that are highly expressed 
in the undifferentiated state, such as Tip110, which we 
identified here, as well as other potential genes. The third 
category had a high expression level on day 1 and down-
regulated expression on day 7, and included miR-132, 
miR-186, miR-199, miR-338, and miR-219. This group 
of miRNAs might be important for regulating genes that 
Figure 4: Up-regulation of constitutive Tip110 mRNA expression by expression of exogenous Tip110 3′UTR. (A) 
Schematic of the Tip110 3′UTR region. The positions of p(A) sites (PA1 and PA2) are shown in solid rectangles. Q1, Q2 and Q3 are primer 
pairs specifically amplified Tip110 mRNA within the open reading frame (ORF), proximal 3′UTR, and distal 3′UTR, respectively. (B) 293T 
were transfected with a plasmid expressing the full-length Tip110 3′UTR RNA or the vector control, cultured for 48 hr, and harvested for 
cell lysates followed by Western blotting for Tip110 protein expression (B), or RNA isolation followed by qRT-PCR using primer pair Q1 
(C), primer pair Q2 (D), or primer pair Q3 (E). β-actin was included as a loading control for both Western blotting and qRT-PCR. The data 
are expressed as mean ± SEM and are representative of three independent experiments.
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are highly expressed in the differentiating state. miRNA 
regulation of gene expression is very complicated in that 
each microRNA regulate thousands of mRNA and each 
mRNA is regulated by many microRNAs [14, 15]. Tip110 
expression level is down-regulated in differentiating 
CD34+ cells. It is reasonable to assume that Tip110 down-
regulation during CD34+ cell differentiation is a combined 
effect of increased microRNA levels targeting 3′UTR of 
Tip110 to down regulate its expression over decreased 
microRNAs of alleviation targeting 3′UTR of Tip110 in 
differentiating CD34+ cells.
Competing endogenous RNA (ceRNA) networks 
basically regulate all biological process [11–13]. We 
hypothesized that expressing non-coding RNA transcripts 
 Table 3: Primers used in the study
Gene GeneBank# Region Forward primer Reverse primer Expected size 
Tip110 NM_014706 ORF: 1465-1629 Q1: CTTCATCCAGGCGACTGATT Q1: TTGAAACGCTCTTCCACCTC 164 bp
3′UTR: 3666-3899 Q2: GTAAATGACATGTCAGCCATTGTTTCATGT Q2: GGCCACGCGTCGACTAGTAC 133 bp
3′UTR: 4296-4399 Q3: TTGTGCATCAGTCGGGTTT Q3: GGTAGGCACACAGGAGTTTATT 103 bp
β-Actin NG_000840 AAACTGGAACGGTGAAGGTG AGAGAAGTGGGGTGGCTTTT 174 bp
Figure 5: Effects of exogenous Tip110 3′UTR expression on human cord blood CD34 cell differentiation and 
hematopoietic colony formation. Human cord blood CD34+ cells were isolated, cultured for one day, and transduced with lentiviruses 
expressing the full-length Tip110 3′UTR RNA. After culturing for 2 days, cells were harvested for RNA isolation followed by qRT-PCR for 
Tip110 expression using primer pair Q1, Q2 or Q3 (A), or for staining followed by flow cytometry analysis for CD34 cell differentiation 
into CD34+CD38−CD45RA−CD90+CD49f+ cells (B), or for hematopoietic colony formation assay (C). The data are mean ± SEM and are 
representative of three independent experiments. 
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of the Tip110 3′UTR may have a dramatic function 
in regulating Tip110 gene expression, an hypothesis 
substantiated when we introduced the 3′UTR RNA to 
core blood CD34+ cells to up-regulate Tip110 expression. 
Since transduction/transfection efficiency in 293T cells 
is much higher compared to core blood CD34+ cells, the 
constitutive Tip110 expression was higher than that of core 
blood CD34+ cells when expressing the Tip110 3′UTR 
RNA (Figures 4 and 5). Our results thus suggest that 
ectopically expressed Tip110 3′UTR RNA acts to compete 
with constitutive Tip110 3′UTR RNA for miRNAs 
binding, resulting in up-regulated expression of Tip110, so 
as to influence HSCs and their differentiation. Expression 
of the 3′UTR may have greater advantage in modulating 
cell activities compared with miRNA inhibitors, in that 
the 3′UTR has the capacity to modulate multiple miRNAs 
(identified and unidentified), providing a potential use for 
3′UTR transcripts. Further mechanistic understanding of 
Tip110 regulation through miRNAs and ceRNA might 
help us identify novel ways to enhance the function of core 
blood HSCs for expansion and clinical transplantation.
MATERIALS AND METHODS
Plasmids
pCSC.GFP was described previously [8]. 
pLighSwitch.Luc-Tip110-3′UTR was purchased from 
SwitchGear Genomics (Carisbad, CA, USA) and 
contained the full-length Tip110 3′UTR (1346 nt). CSC-
Tip110-3′UTR was constructed to express Tip110 3′UTR 
RNA by cloning the Tip110 3′UTR into pCSC.GFP.
miRNA analysis
For each RNA sample, 500 ng RNA was used to 
prepare cDNA using a qScript microRNA cDNA Synthesis 
Kit (Quanta PN 95107). After cDNA synthesis, an 
equivalent of 10 ng the original RNA sample was mixed 
with Perfecta SYBR Green SuperMix (Quanta PN 95054) 
and Universal PCR Primer (Quanta PN 95109) with each 
PerfeCta microRNA Assay Primer (miR-193a-3p, miR-
300, miR-186-5p, miR-494, miR-199a-5p, miR-210-1-3p, 
miR-338-3p, miR-132a-3p, miR-148a-3p, and miR-124a-
3p) in 10 μl qPCR reactions. The qPCR plates were run in 
a CFX96 real-time PCR detection system (Bio-Rad) using 
a two-step cycling protocol (95°C for 2 min followed by 
40 cycles of 95°C for 10 s and 60°C for 30 s) and followed 
by a melting curve. Threshold cycle (CT) values were 
calculated using Bio-Rad CFX manager software. 2(-DDCT) 
value was calculated to represent the fold change of the 
target gene mRNA. 
Cells, cell transfection, and luciferase reporter 
gene assay
293T were purchased from ATCC. Human core 
blood was collected and used as reported [8, 9]. CD34+ 
cells were purified within 24 hr of collection using 
immunomagnetic selection (Miltenyi Biotec). CD34+ 
cells (>93% pure) were cultured in IMDM containing 
1% or 10% FBS with 100 ng/mL of human stem cell 
factor (SCF), 100 ng/mL human FLT3 ligand (FL), and 
100 ng/mL of human thrombopoietin (Tpo) from R&D 
Systems (Minneapolis, MN, USA). Cell transfections were 
Figure 6: Schematic of Tip110 regulation mechanism through miRNAs and ceRNA. Tip110 miRNAs bind to Tip110 3′UTR 
and lead to regulated Tip110 protein expression (left); In the presence of exogenous Tip110 3′UTR (ce3′UTR), ce3′UTR bind to Tip110 
miRNAs, which leads to binding of less Tip110 miRNA to Tip110 3′UTR and increased Tip110 protein expression (right).
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performed on the Nucleofector device (Amaxa Biosystem) 
according to the manufacturer’s instructions [16]. pcDNA3 
was used to equalize amounts of DNA transfected for all 
transfections. Luciferase reporter gene activities were 
determined using the Firefly/Renilla luciferase system 
(Promega, Madison, WI, USA). pTKβGal was included 
to normalize variations in transfection efficiency for all 
transfections. miRNA transfections used Lipofectamine 
2000 LTX (Invitrogen).
Preparation of whole cell lysates and Western 
blotting
 Cells were washed twice with ice-cold PBS 
and then harvested for whole cell lysates [17]. Briefly, 
cell pellets were suspended in two volumes of whole 
cell lysis buffer (10 mM NaHPO4, 150 mM NaCl, 1% 
Triton X-100, 0.1% SDS, 0.2% sodium azide, 0.5% 
sodium deoxycholate, 0.004% sodium fluoride, and 1 
mM sodium orthovanadate), and incubated on ice for 10 
min. Whole cell lysates were obtained by centrifugation 
and removal of the cell debris. For Western blotting, 
cell lysates were electrophoretically separated on 10% 
SDS-PAGE and analyzed by immunoblotting using an 
anti-Tip110 antibody [8] and appropriate horseradish 
peroxidase-conjugated secondary antibodies, followed by 
visualization with the ECL system (GE Healthcare Bio-
sciences, Pittsburgh, PA, USA).
RNA isolation and qRT-PCR Total RNA was 
extracted using TRizol (Life Technology, Grand Island, 
NY, USA) according to the manufacturer’s instructions. 
cDNA was synthesized using a ScriptII RT Reagent 
Kit (Promega). cDNAs were used for qPCR performed 
by Power SYBR® Green PCR kit (Life Technologies, 
Grand Island, NY, USA) according to the manufacturer’s 
instructions. Primers for Tip110 and actin were described 
previously [18]. The qPCR program consisted of 1 cycle 
of 95°C for 10 min; 40 cycles of 95°C for 15 sec and 
60°C for 1 min. Bio-Rad CFX manager software was 
used for calculating gross-threshold (CT) values. The 
2(-ΔΔCT) was calculated to represent the fold change of gene 
expressions. mRNA were normalized using β-actin as the 
reference.
Flow cytometry analysis of human core blood 
CD34+ cells 
Freshly purified and cultured human core blood 
CD34+ cells from the different experimental groups 
were washed twice with PBS and stained with mouse 
anti-human CD34-PE/CD34-APC/CD34-FITC antibody, 
mouse antihuman CD38-PE antibody, mouse anti-human 
CD45RA-PECF594, mouse anti-human CD90-PECy7, 
and mouse anti-human CD49f-PerCPCy5.5 in the dark at 
room temperature for 30 min. All antibodies were from 
BD Biosciences (San Jose, CA, USA). Mouse IgG-FITC, 
mouse IgGAPC, and mouse IgG-PE were included as 
negative controls. Cells were subjected to FACS flow 
cytometric analysis (Becton Dickinson).
Lentivirus transduction and in vitro 
hematopoietic colony-forming cell assay
Tip110-3′UTR.GFP lentivirus preparation and 
transduction were described previously [7]. Human 
core blood CD34+ cells were seeded in triplicate onto 
35 mm dishes at a density of 250 cells per dish in 
1.0 ml of 1% methylcellulose culture medium containing 100 
mM 2-mercaptoethanl, 2 mM L-glutamine, 30% fetal bovine 
serum (FBS; Hyclone Laboratories, Logan, UT, USA). 
Recombinant human erythropoietin (1 U/ml), SCF (50 ng/
ml), human interleukin-3 (IL-3; 10 ng/ml), and granulocyte 
macrophage colony stimulating factor (GM-CSF; 10 ng/ml) 
were included in the culture medium to stimulate colonies 
from multipotential (CFU-GEMM), and granulocyte 
macrophage (CFU-GM) progenitor cells. Epo was purchased 
from Amgen Inc. (Thousand Oaks, CA, USA). IL-3 and GM-
CSF, were purchased from R & D Systems (Minneapolis, 
MN, USA). Colonies were scored after 14 days incubation 
at 5% CO2 and lowered (5%) O2 tension [19].
Statistical analysis
Data are mean ± SD, unless otherwise noted and are 
representative of at least three independent experiments. 
All experimental data were analyzed by 2-tailed student’s 
t-test.
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